Sfoglia per Autore
Long-term effects of iron chelating agents on ocular function in patients with thalassemia major
2021-01-01 Nuzzi R.; Geronazzo G.; Tridico F.; Nuzzi A.; Caselgrandi P.; Piga A.G.
Pharmacological and clinical evaluation of deferasirox formulations for treatment tailoring
2021-01-01 Andrea Piolatto, Paola Berchialla, Sarah Allegra, Silvia De Francia, Giovanni Battista Ferrero, Antonio Piga, Filomena Longo
Children and coronavirus: The necessary search for a balance between the alleged risks and documented collateral damage
2020-01-01 Tamburlini G.; Marchetti F.; Bertino E.; Bestetti G.; Biasucci G.; Biondi A.; Bonati M.; Brunelli A.; Corsello G.; Esposito S.; Fagioli F.; Farina D.; Gagliardi L.; Gangemi M.; Greco L.; Lanari M.; Lazzerini M.; Maggiore G.; Martelossi S.; Ramenghi U.; Piga A.; Selicorni A.; Spada M.; Ventura A.; Vicari S.; Zampino G.; Zanetto F.
Challenges of blood transfusions in β-thalassemia
2019-01-01 Shah F.T.; Sayani F.; Trompeter S.; Drasar E.; Piga A.
Current challenges in the management of patients with sickle cell disease - A report of the Italian experience
2019-01-01 Russo G.; De Franceschi L.; Colombatti R.; Rigano P.; Perrotta S.; Voi V.; Palazzi G.; Fidone C.; Quota A.; Graziadei G.; Pietrangelo A.; Pinto V.; Ruffo G.B.; Sorrentino F.; Venturelli D.; Casale M.; Ferrara F.; Sainati L.; Cappellini M.D.; Piga A.; Maggio A.; Forni G.L.
Prevalence and prognostic impact of left ventricular non-compaction in patients with thalassemia
2019-01-01 Bonamini R.; Imazio M.; Faletti R.; Gatti M.; Xhyheri B.; Limone M.; Longo F.; Piga A.
Risk factors for heart disease in transfusion-dependent thalassemia: serum ferritin revisited
2019-01-01 Derchi G.; Dessi C.; Bina P.; Cappellini M.D.; Piga A.; Perrotta S.; Tartaglione I.; Giuditta M.; Longo F.; Origa R.; Quarta A.; Pinto V.; Forni G.L.
Gender differences in five different drug pharmacokinetics
2019-01-01 S. Allegra, S. De Francia, A. E. Sprio, M. De Gobbi, A. Piga, A. De Nicolò, M. Antonucci, A. D’Avolio, S. Racca
Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with b-thalassemia
2019-01-01 Piga A.; Perrotta S.; Gamberini M.R.; Voskaridou E.; Melpignano A.; Filosa A.; Caruso V.; Pietrangelo A.; Longo F.; Tartaglione I.; Borgna-Pignatti C.; Zhang X.; Laadem A.; Sherman M.L.; Attie K.M.
Amustaline-glutathione pathogen-reduced red blood cell concentrates for transfusion-dependent thalassaemia
2019-01-01 Aydinok Y.; Piga A.; Origa R.; Mufti N.; Erickson A.; North A.; Waldhaus K.; Ernst C.; Lin J.-S.; Huang N.; Benjamin R.J.; Corash L.
The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients
2019-01-01 Allegra, Sarah; Cusato, Jessica; De Francia, Silvia; Longo, Filomena; Pirro, Elisa; Massano, Davide; Avataneo, Valeria; De Nicolò, Amedeo; Piga, Antonio; D'Avolio, Antonio
Atrial fibrillation in β-thalassemia Major Patients: Diagnosis, Management and Therapeutic Options
2018-01-01 Barbero U, Fornari F, Guarguagli S, Gaglioti CM, Longo F, Doronzo B, Anselmino M, Piga A.
Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children
2018-01-01 Allegra, Sarah; Cusato, Jessica; De Francia, Silvia; Longo, Filomena; Pirro, Elisa; Massano, Davide; Piga, Antonio; D'Avolio, Antonio
Clinical relevance of deferasirox trough levels in β-thalassemia patients
2018-01-01 Allegra, Sarah; Massano, Davide; De Francia, Silvia; Longo, Filomena; Piccione, Francesca; Pirro, Elisa; Cusato, Jessica; D'Avolio, Antonio; Piga, Antonio
Transient elastography for non-invasive evaluation of post-transplant liver graft fibrosis in children
2018-01-01 Vinciguerra, Tiziana; Brunati, Andrea; David, Ezio; Longo, Filomena; Pinon, Michele; Ricceri, Fulvio; Castellino, Luisa; Piga, Antonio; Giraudo, Maria Teresa; Tandoi, Francesco; Cisarò, Fabio; Dell Olio, Dominic; Isolato, Giuseppe; Romagnoli, Renato; Salizzoni, Mauro; Calvo, Pier Luigi*
Dual-Energy X-ray Absorptiometry Predictors of Vertebral Deformities in Beta-Thalassemia Major
2018-01-01 Osella, G1; Priola, adriano massimiliano; Priola, Sandro Massimo; Piga, Antonio Giulio; Longo, Filomena; Ventura, Massimo; Bentivegna, Giuseppe; Angeli, Alberto; Veltri, Andrea; Terzolo, Massimo
Real-life experience with hydroxyurea in sickle cell disease: A multicenter study in a cohort of patients with heterogeneous descent
2018-01-01 Rigano, Paolo; De Franceschi, Lucia; Sainati, Laura; Piga, Antonio; Piel, Frederic B; Cappellini, Maria Domenica; Fidone, Carmelo; Masera, Nicoletta; Palazzi, Giovanni; Gianesin, Barbara; Forni, Gian Luca
Renal safety under long-course deferasirox therapy in iron overloaded transfusion-dependent β-thalassemia and other anemias
2018-01-01 Origa R.; Piga A.; Tartaglione I.; Della Corte G.; Forni G.L.; Bruederle A.; Castiglioni C.; Han J.
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes
2018-01-01 Allegra, Sarah; Cusato, Jessica; DE FRANCIA, Silvia; Arduino, A; Longo, Filomena; Pirro, Elisa; Massano, Davide; DE NICOLO', Amedeo; Piga, Antonio Giulio; D'Avolio, Antonio
Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients
2018-01-01 Allegra, Sarah; Cusato, Jessica; De Francia, Silvia; Longo, Filomena; Pirro, Elisa; Massano, Davide; Avataneo, Valeria; De Nicolò, Amedeo; Piga, Antonio; D'Avolio, Antonio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Long-term effects of iron chelating agents on ocular function in patients with thalassemia major | 2021 | Nuzzi R.; Geronazzo G.; Tridico F.; Nuzzi A.; Caselgrandi P.; Piga A.G. | |
| Pharmacological and clinical evaluation of deferasirox formulations for treatment tailoring | 2021 | Andrea Piolatto, Paola Berchialla, Sarah Allegra, Silvia De Francia, Giovanni Battista Ferrero, Antonio Piga, Filomena Longo | |
| Children and coronavirus: The necessary search for a balance between the alleged risks and documented collateral damage | 2020 | Tamburlini G.; Marchetti F.; Bertino E.; Bestetti G.; Biasucci G.; Biondi A.; Bonati M.; Brunelli A.; Corsello G.; Esposito S.; Fagioli F.; Farina D.; Gagliardi L.; Gangemi M.; Greco L.; Lanari M.; Lazzerini M.; Maggiore G.; Martelossi S.; Ramenghi U.; Piga A.; Selicorni A.; Spada M.; Ventura A.; Vicari S.; Zampino G.; Zanetto F. | |
| Challenges of blood transfusions in β-thalassemia | 2019 | Shah F.T.; Sayani F.; Trompeter S.; Drasar E.; Piga A. | |
| Current challenges in the management of patients with sickle cell disease - A report of the Italian experience | 2019 | Russo G.; De Franceschi L.; Colombatti R.; Rigano P.; Perrotta S.; Voi V.; Palazzi G.; Fidone C.; Quota A.; Graziadei G.; Pietrangelo A.; Pinto V.; Ruffo G.B.; Sorrentino F.; Venturelli D.; Casale M.; Ferrara F.; Sainati L.; Cappellini M.D.; Piga A.; Maggio A.; Forni G.L. | |
| Prevalence and prognostic impact of left ventricular non-compaction in patients with thalassemia | 2019 | Bonamini R.; Imazio M.; Faletti R.; Gatti M.; Xhyheri B.; Limone M.; Longo F.; Piga A. | |
| Risk factors for heart disease in transfusion-dependent thalassemia: serum ferritin revisited | 2019 | Derchi G.; Dessi C.; Bina P.; Cappellini M.D.; Piga A.; Perrotta S.; Tartaglione I.; Giuditta M.; Longo F.; Origa R.; Quarta A.; Pinto V.; Forni G.L. | |
| Gender differences in five different drug pharmacokinetics | 2019 | S. Allegra, S. De Francia, A. E. Sprio, M. De Gobbi, A. Piga, A. De Nicolò, M. Antonucci, A. D’Avolio, S. Racca | |
| Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with b-thalassemia | 2019 | Piga A.; Perrotta S.; Gamberini M.R.; Voskaridou E.; Melpignano A.; Filosa A.; Caruso V.; Pietrangelo A.; Longo F.; Tartaglione I.; Borgna-Pignatti C.; Zhang X.; Laadem A.; Sherman M.L.; Attie K.M. | |
| Amustaline-glutathione pathogen-reduced red blood cell concentrates for transfusion-dependent thalassaemia | 2019 | Aydinok Y.; Piga A.; Origa R.; Mufti N.; Erickson A.; North A.; Waldhaus K.; Ernst C.; Lin J.-S.; Huang N.; Benjamin R.J.; Corash L. | |
| The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients | 2019 | Allegra, Sarah; Cusato, Jessica; De Francia, Silvia; Longo, Filomena; Pirro, Elisa; Massano, Davide; Avataneo, Valeria; De Nicolò, Amedeo; Piga, Antonio; D'Avolio, Antonio | |
| Atrial fibrillation in β-thalassemia Major Patients: Diagnosis, Management and Therapeutic Options | 2018 | Barbero U, Fornari F, Guarguagli S, Gaglioti CM, Longo F, Doronzo B, Anselmino M, Piga A. | |
| Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children | 2018 | Allegra, Sarah; Cusato, Jessica; De Francia, Silvia; Longo, Filomena; Pirro, Elisa; Massano, Davide; Piga, Antonio; D'Avolio, Antonio | |
| Clinical relevance of deferasirox trough levels in β-thalassemia patients | 2018 | Allegra, Sarah; Massano, Davide; De Francia, Silvia; Longo, Filomena; Piccione, Francesca; Pirro, Elisa; Cusato, Jessica; D'Avolio, Antonio; Piga, Antonio | |
| Transient elastography for non-invasive evaluation of post-transplant liver graft fibrosis in children | 2018 | Vinciguerra, Tiziana; Brunati, Andrea; David, Ezio; Longo, Filomena; Pinon, Michele; Ricceri, Fulvio; Castellino, Luisa; Piga, Antonio; Giraudo, Maria Teresa; Tandoi, Francesco; Cisarò, Fabio; Dell Olio, Dominic; Isolato, Giuseppe; Romagnoli, Renato; Salizzoni, Mauro; Calvo, Pier Luigi* | |
| Dual-Energy X-ray Absorptiometry Predictors of Vertebral Deformities in Beta-Thalassemia Major | 2018 | Osella, G1; Priola, adriano massimiliano; Priola, Sandro Massimo; Piga, Antonio Giulio; Longo, Filomena; Ventura, Massimo; Bentivegna, Giuseppe; Angeli, Alberto; Veltri, Andrea; Terzolo, Massimo | |
| Real-life experience with hydroxyurea in sickle cell disease: A multicenter study in a cohort of patients with heterogeneous descent | 2018 | Rigano, Paolo; De Franceschi, Lucia; Sainati, Laura; Piga, Antonio; Piel, Frederic B; Cappellini, Maria Domenica; Fidone, Carmelo; Masera, Nicoletta; Palazzi, Giovanni; Gianesin, Barbara; Forni, Gian Luca | |
| Renal safety under long-course deferasirox therapy in iron overloaded transfusion-dependent β-thalassemia and other anemias | 2018 | Origa R.; Piga A.; Tartaglione I.; Della Corte G.; Forni G.L.; Bruederle A.; Castiglioni C.; Han J. | |
| Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes | 2018 | Allegra, Sarah; Cusato, Jessica; DE FRANCIA, Silvia; Arduino, A; Longo, Filomena; Pirro, Elisa; Massano, Davide; DE NICOLO', Amedeo; Piga, Antonio Giulio; D'Avolio, Antonio | |
| Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients | 2018 | Allegra, Sarah; Cusato, Jessica; De Francia, Silvia; Longo, Filomena; Pirro, Elisa; Massano, Davide; Avataneo, Valeria; De Nicolò, Amedeo; Piga, Antonio; D'Avolio, Antonio |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile